SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril) -Induced Cough: a Pharmacogenetic Study

@inproceedings{Luo2015SLCO1B1VA,
  title={SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril) -Induced Cough: a Pharmacogenetic Study},
  author={Jian-Quan Luo and Fa-zhong He and Zhen-Min Wang and Ning-ling Sun and Lu-yan Wang and Gen-fu Tang and Mou-Ze Liu and Qing Li and Xiaoping Chen and Zhaoqian Liu and Hong-hao Zhou and Wei Zhang},
  booktitle={Scientific reports},
  year={2015}
}
Clinical observations suggest that incidence of cough in Chinese taking angiotensin converting enzyme inhibitors is much higher than other racial groups. Cough is the most common adverse reaction of enalapril. We investigate whether SLCO1B1 genetic polymorphisms, previously reported to be important determinants of inter-individual variability in enalapril pharmacokinetics, are associated with the enalapril-induced cough. A cohort of 450 patients with essential hypertension taking 10 mg… CONTINUE READING
3 Citations
60 References
Similar Papers

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 60 references

2014 update

  • Ramsey, L. B. et al. The clinical pharmacogenetics implementa SLCO1B1, simvastatin-induced myopathy
  • Clin Pharmacol Ther 96, 423–428
  • 2014

The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease

  • Brugts, J J.
  • Int J Cardiol 176,
  • 2014

Similar Papers

Loading similar papers…